A. Glanz

发表

Randomized Trial of Percutaneous Coronary Intervention for Subacute Infarct-Related Coronary Artery Occlusion to Achieve Long-Term Patency and Improve Ventricular Function: The Total Occlusion Study of Canada (TOSCA)–2 Trial

G. Lamas, G. Knatterud, C. Buller, 2006, Circulation.

The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.

Janzen, A. M. Møller, D. Debanne, 1996, The Canadian journal of cardiology.

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.

Khalid Yusoff, Frederick M. Costello, Martin O'Donnell, 2017, Lancet.

Giant Calcified Left Ventricular Aneurysm with Calcified Thrombus Following Remote Myocardial Infarction

P. Teefy, A. Glanz, Max Deschner, 2022, Canadian Journal of General Internal Medicine.

Spectrum of anomalies in Fanconi anaemia.

F. Fraser, A. Glanz, Anthony Glanz, 1982, Journal of medical genetics.

Case report: Unusual presentation of haemopericardium with haemodynamic instability secondary to a coronary graft pseudoaneurysm treated by an endovascular approach

T. Burke, A. Glanz, A. Haghighat, 2018, European heart journal. Case reports.

OP-EHCR180154 1..5

T. Burke, A. Glanz, A. Haghighat, 2018 .

Risk estimates for neonatal myotonic dystrophy.

F. Fraser, A. Glanz, 1984, Journal of medical genetics.

Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.

A. Glanz, P. S. Hansen, Jens Cosedis Nielsen, 2013, The New England journal of medicine.

Antithrombotic Therapies in Canadian Atrial Fibrillation Patients with Concomitant Coronary Artery Disease: Insights from the CONNECT AF+PCI-II Program.

A. Bagai, W. Cantor, A. Yan, 2021, Journal of cardiology.